Literature DB >> 12930573

Ovarian hyperstimulation syndrome: strategies for prevention.

Dehan Chen1, Lynn Burmeister, Dan Goldschlag, Zev Rosenwaks.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is a serious, iatrogenic complication of ovarian stimulation. The following report is a review of traditional and new strategies to prevent the development of OHSS. Techniques such as reducing the ovarian stimulus, coasting and cryopreservation are discussed. Other more investigative strategies are also summarized, including follicular aspiration, in-vitro maturation of immature oocytes, the use of gonadotrophin-releasing hormone (GnRH) agonists to trigger ovulation and the use of volume expanders such as hydroxyethyl starch. In addition, a review of the internal experience with OHSS at the authors' institution is described. All these preventative approaches are based on current understanding of the physiologic mechanisms involved in the pathogenesis of OHSS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12930573     DOI: 10.1016/s1472-6483(10)61727-0

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  9 in total

1.  Application of GnRH antagonist in combination with clomiphene citrate and hMG for patients with exaggerated ovarian response in previous IVF/ICSI cycles.

Authors:  Yu-Hung Lin; Kok-Min Seow; Bih-Chwen Hsieh; Lee-Wen Huang; Heng-Ju Chen; Shih-Chia Huang; Chih-Yu Chen; Pei-Hsin Chen; Jiann-Loung Hwang; Chi-Ruey Tzeng
Journal:  J Assist Reprod Genet       Date:  2007-07-17       Impact factor: 3.412

2.  Predictive value of initial serum human chorionic gonadotropin levels for pregnancies after single fresh and frozen blastocyst transfer.

Authors:  Wei-E Zhao; Yu-Jie Li; Jian-Ping Ou; Peng Sun; Wen-Qiu Chen; Xiao-Yan Liang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06

3.  Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome.

Authors:  Nikita Naredi; Sandeep Karunakaran
Journal:  J Hum Reprod Sci       Date:  2013-10

4.  Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure?

Authors:  Ömer Hamid Yumuşak; Serkan Kahyaoğlu; Ayşe Seval Özgü Erdinç; Saynur Yılmaz; Yaprak Engin Üstün; Nafiye Yılmaz
Journal:  Turk J Obstet Gynecol       Date:  2014-09-15

5.  Sliding scale HCG trigger yields equivalent pregnancy outcomes and reduces ovarian hyperstimulation syndrome: Analysis of 10,427 IVF-ICSI cycles.

Authors:  Vinay Gunnala; Alexis Melnick; Mohamad Irani; David Reichman; Glenn Schattman; Owen Davis; Zev Rosenwaks
Journal:  PLoS One       Date:  2017-04-25       Impact factor: 3.240

6.  Gonadotropin levels at the start of ovarian stimulation predict normal fertilization after hCG re-trigger in GnRH antagonist cycles.

Authors:  Hiroya Kitasaka; Mikiko Tokoro; Masae Kojima; Noritaka Fukunaga; Yoshimasa Asada
Journal:  Reprod Med Biol       Date:  2020-12-18

7.  Impact of L-carnitine supplementation on the in vitro developmental competence and cryotolerance of buffalo embryos.

Authors:  Mohamed M M El-Sokary; Al-Shimaa Al-H H El-Naby; Amal R Abd El Hameed; Karima Gh M Mahmoud; T H Scholkamy
Journal:  Vet World       Date:  2021-12-26

8.  Severe ovarian hyperstimulation syndrome: Can we eliminate it through a multipronged approach?

Authors:  Nikita Naredi; S K Singh; Prasad Lele; N Nagraj
Journal:  Med J Armed Forces India       Date:  2017-06-19

Review 9.  Volume expanders for the prevention of ovarian hyperstimulation syndrome.

Authors:  Mohamed A Youssef; Selma Mourad
Journal:  Cochrane Database Syst Rev       Date:  2016-08-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.